A New Radiation Therapy Procedure Using The “Bystander Effect” Could Make Mesothelioma Treatment More Effective
ulleo / Pixabay

A New Radiation Therapy Procedure Using The “Bystander Effect” Could Make Mesothelioma Treatment More Effective

According to a story from abc.net.au, a team of Australian scientists have developed a technique for delivering radiation therapy that could enhance both the potency and safety of treatment. This…

Continue Reading A New Radiation Therapy Procedure Using The “Bystander Effect” Could Make Mesothelioma Treatment More Effective
Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment
nattanan23 / Pixabay

Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment

According to a story from the St. Helens Star, Amanda Sackville-Wiggins was diagnosed with hepatocellular carcinoma, a rare type of liver cancer, just after her 21st birthday. The cancer was…

Continue Reading Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment

A Trove of Brain Cancer Data Just Became Available to Researchers

According to a story from healthnewsdigest.com, an important source of data related to brain cancer has just become widely available to global researchers. This dataset was supported by Georgetown University,…

Continue Reading A Trove of Brain Cancer Data Just Became Available to Researchers
Scientists Have Managed to Create a Mouse Model for Idiopathic Pulmonary Fibrosis
Free-Photos / Pixabay

Scientists Have Managed to Create a Mouse Model for Idiopathic Pulmonary Fibrosis

According to a story from EurakAlert!, a group of researchers from the University of Pennsylvania School of Medicine have achieved a major breakthrough for idiopathic pulmonary fibrosis research that will…

Continue Reading Scientists Have Managed to Create a Mouse Model for Idiopathic Pulmonary Fibrosis

A Treatment for Paroxysmal Nocturnal Hemoglobinuria Was Accepted for Priority Review

According to a story from Morningstar, the company Alexion Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) has agreed to review their Biologics Licensing Application for their…

Continue Reading A Treatment for Paroxysmal Nocturnal Hemoglobinuria Was Accepted for Priority Review
Experimental Duchenne Muscular Dystrophy Drug Gets Multiple Designations From the FDA
jarmoluk / Pixabay

Experimental Duchenne Muscular Dystrophy Drug Gets Multiple Designations From the FDA

According to a story from Globe Newswire, the biotechnology company Wave Life Sciences recently announced that its investigational product WVE-210201 has received both Rare Pediatric disease designation and Orphan Drug…

Continue Reading Experimental Duchenne Muscular Dystrophy Drug Gets Multiple Designations From the FDA